Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. Mark R. Newton, M.D.
EIR
•Mark R. Newton, M.D.•September 23, 2021

Mark R. Newton, M.D. – FDA EIR, Sep 23, 2021

Record Details

An FDA inspection was conducted at the clinical research site of Dr. Mark R. Newton, Clinical Investigator, located at UnityPoint Health Allen Hospital – Center for Urology in Waterloo, IA, from September 20-23, 2021. This was a For-Cause, pre-market investigational device exemption (IDE) inspection supporting the Premarketing Application for the eCoin® electroceutical device for overactive bladder, regulated by the FDA's Center for Devices and Radiological Health. The inspection revealed five primary observations. Firstly, the enrollment and implantation of study devices in ineligible subjects who did not meet inclusion or had exclusionary criteria. Secondly, major deviations from the investigational plan were initiated without prior approval from the sponsor and Institutional Review Board (IRB). Thirdly, these major deviations were improperly classified as minor, leading to a failure to report them to the IRB as required. Fourthly, Dr. Newton had not completed a financial disclosure form detailing his interests in the study product, nor had he signed an Investigator Agreement. Lastly, annual continuing review reports submitted to the IRB contained inaccurate subject counts for screen fails, lost-to-follow-up individuals, and subjects who completed the study. Dr. Newton and site management acknowledged the findings and committed to providing a written response within 15 business days. Corrective actions include ensuring strict adherence to eligibility criteria, obtaining prior approval for protocol changes, accurately classifying and reporting deviations to the IRB, completing all necessary financial disclosures and investigator agreements, and improving overall documentation practices.

Company
Mark R. Newton, M.D.
Inspection date
September 23, 2021
Product type
Devices
Office
Center for Biologics Evaluation and Research
People
  • Kellie L. Thommes (Consumer Safety Officer)
  • Bilal Kaaki (company_representative)
  • Mark Newton (company_representative)
  • Kelly Nardone (other)
  • Jackie Dister (other)
View Company Profile

ID · a47e3174-15b4-4574-9b60-f4e0b6849031

Violation Codes1
21 CFR 312

Full citation text and observation details available on the Dashboard.

Other documents for Mark R. Newton, M.D.
  • 483 - 2021-09-23September 23, 2021

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Mark R. Newton, M.D.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.